The Claimed Intermediate Online Database and Reports cover Process Patents for Marketed Pharmaceutical Drugs and the Intermediates used therein.

• Unique Online Database allows Intermediate/API/INN text and structure searching
• Includes API/INNs in at least one major Market
• Locates Drug Synthesis often buried in a Plethora of Patents
• Provides targeted Patent data in a Visual form
• Drug syntheses obtained by analysing Patent documents

• Subscription-based, no additional hit costs
• Save on patent searching/analysis
• Only new applications, no repeated equivalents
• Reduce manpower cost
• Informs Commercial Synthesis profitability

• 875+ Drugs • 3850+ Patents • 25,000+ Structures • 4000+ Records with 1150+ Claimed Intermediates • 1250+ Patentees including Joint Patentees &c

Top Database Records:

Atorvastatin, Rosuvastatin, Sitagliptin, Dronedarone, Rivaroxaban, Ticagrelor, Lacosamide, Dabigatran etexilate, Ivabradine, Tapentadol, Pregabalin, Agomelatine, Apremilast, Aliskiren, Sofosbuvir, Telaprevir, Iodixanol, Vilazodone



Try the Free Quarterly Report in the Shop.

What is a Claimed Intermediate?
A Claimed Intermediate is here defined as a novel pharmaceutical process intermediate which is preferably highly stable, highly isolatable, highly purifiable (optionally with appropriate chirality) and claimed as a compound in a pharmaceutical process patent specification from which it may be subject to a 20 year patent protection term.